Union Minister Piyush Goyal met with Indian pharmaceutical industry leaders to boost growth and strengthen regulatory frameworks. Despite concerns over potential US tariffs on some drugs, industry representatives expressed confidence that India's focus on generic drugs and APIs will shield its exports, reinforcing its global position.